Nasdaq News
With a Growing AI-Driven Cybersecurity Platform, $112 Million Contract Backlog, and Strategic Acquisitions, Cycurion $CYCU May Be Positioned for Significant Long-Term Growth
Following a transformational acquisition, record financial growth, and more than $600 million in recent public-sector contract awards, Circle8 Group $CIRC is positioning itself as a leading global technology and workforce solutions platform.
From Space Force initiatives and NASA collaborations to commercial satellite constellations, autonomous systems and advanced defense applications, Ascent Solar, $ASTI continues expanding the real-world deployment of its proprietary lightweight thin-film s
Twelve Surgical Centers, Strong Financial Momentum, And A Scalable Growth Strategy Position $CDIX For Its Next Phase Of Expansion
First Commercial Deployment of FDA-Cleared AI-Guided TMS Navigation System, Expanded FDA Pathway for NRX-101, and Growing Commercial Infrastructure Highlight Accelerating Momentum for NRx Pharmaceuticals (N A S D A Q: NRXP)
Strategic Business Transformation, Enterprise Healthcare Expansion, AI-Powered Telehealth Innovation, And Significant Cost Reductions Position $VSEE Health For Potential Multi-Year Growth
Cycurion, Inc. (N A S D A Q: CYCU): Acquisitions of Halo Privacy, HavenX, Secuvant, plus Expanding Government Contracts, Strong Revenue Visibility, And Significant Operating Improvements Position Cycurion For Potential Multi-Year Growth
Cosmos Health Inc. (N A S D A Q: COSM): 18 Series Nutraceutical Expansion, Record Q1 Results, EIB Financing Initiative, AI-Powered Drug Development, And Strong Long-Term Financial Guidance Position Cosmos Health For Potential Multi-Year Expansion
Cosmos Health Inc. (N A S D A Q: COSM): Veterinary Expansion, Proprietary Healthcare Brands, AI-Powered Drug Development, Telehealth Growth, and Strong Financial Guidance Position Cosmos Health for Potential Multi-Year Expansion
$IQST Delivering Nearly 70% Growth and Gross profit increased 7.8% to $2.08 million
Expanding HOPE Therapeutics Network Positions NRx Pharmaceuticals, Inc. (N A S D A Q: NRXP) $NRXP for Potential Breakout 2026 Growth
NRx Pharmaceuticals, Inc.Improved Financial Position, Commercial Ketamine Manufacturing, FDA Progress, and Expanding Neuroplastic Therapy Infrastructure Position $NRXP for a Potential Breakout Phase
$CDIX Continues Scaling Its Orthopedic, Spine, and Pain Management Footprint as Revenue Growth, Margin Expansion, and Capital Markets Momentum Accelerate
RF sensing, counter-drone technologies, autonomous platforms and QuantumSpeed™ AI infrastructure initiatives position $VWAV for growth across global defense modernization and AI infrastructure markets.
XMax Inc., (N A S D A Q: XWIN) $XWIN Has a $5.60 Million Investment in a Fund That Holds Interest in SpaceX Shares.
Operational AI Platform, Recurring Enterprise Revenue, 73% Annual Growth and SpaceX-Linked Investments Position $XWIN as an Emerging Multi-Sector AI Infrastructure and Technology Growth Story
Commercial-Ready Ketamine Production, FDA Alignment, and Expanding AI Neurotherapy Platform Position $NRXP at the Center of a Multi-Billion-Dollar Mental Health Transformation
$MWYN Enters Into Critical EV Materials, NexaCore AI Rollout, and EcoLoopX Global Expansion, Marwynn Is Building a Multi-Layered Growth Engine at the Intersection of AI, Circular Economy, and Battery Supply Chains
Sow Good Inc. (N A S D A Q: SOWG) $SOWG World-Class Tanzanian Graphite Asset, Strengthened Balance Sheet, Retail Expansion, and Aggressive Cost Discipline, Positions Itself as a Rare Hybrid Play
$MWYN NexaCore Launch and Strategic DJ Mex Acquisition, Marwynn Positions Itself at the Intersection of AI's Explosive Demand and High-Margin Global Supply Chain Transformation